Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
about
Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes VirusViral profiling identifies multiple subtypes of Kaposi's sarcoma.Treatment outcomes of AIDS-associated Kaposi's sarcoma under a routine antiretroviral therapy program in Lilongwe, Malawi: bleomycin/vincristine compared to vincristine monotherapy.Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma.KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle.Lymphangioma-Like Kaposi's Sarcoma Presenting as Gangrene.KSHV targeted therapy: an update on inhibitors of viral lytic replication.For the Future Studies of Kaposi's Sarcoma-Associated Herpesvirus.Detection of Human Herpes Virus 8 in Kaposi's sarcoma tissues at the University Teaching Hospital, Lusaka, Zambia.KSHV and the Role of Notch Receptor Dysregulation in Disease Progression.AIDS-related Kaposi's sarcoma in Brazil: trends and geopolitical distribution.Human herpesvirus 6, 7 and 8 in solid organ transplantation.RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.Role of Pattern Recognition Receptors in KSHV Infection.
P2860
Q26743368-43F53DA6-7D71-4A38-BCB4-0705223792AFQ34237734-84429070-8623-4B95-971D-E151718301F0Q35121796-63E9895C-01C9-4BF0-BDF5-264EDE30185FQ35158385-9DFADDB3-D1B3-43FF-A0F2-37C883FF6A27Q35770551-227E061D-4479-40C1-9257-70A26A6EB7DDQ36318661-2A5AB2A7-BF90-4CD6-95AD-91D7BAC20442Q36414290-B1A74399-CA6E-480E-B1F4-3A0B86BD1302Q36916063-32B91BAB-3FEF-4BBE-8A6E-3A428130D663Q38271135-3762C0B1-85D4-405C-8BA6-BB7F3C05C43CQ39585656-6FCFA677-CBA9-49C6-B572-F8E229309370Q40042151-501B7373-1BFD-4D3D-8991-BAD39F775721Q41662283-2C4CD938-3F16-4B94-9DA0-CD695B67BB1FQ42261797-A145DCF4-888C-435A-B5CC-4EB08C9DBDFCQ42272326-1C1A236D-0EF3-41EC-8A85-8942DE8929C7Q47551073-184A5D21-94A8-4D42-8AEC-D92DD123302FQ55338587-4C1FCF30-2B64-4EE1-A58A-569C3B3808E0
P2860
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
@ast
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
@en
type
label
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
@ast
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
@en
prefLabel
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
@ast
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
@en
P2860
P356
P1476
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.
@en
P2093
Dirk P Dittmer
Kristy L Richards
P2860
P356
10.3389/FMICB.2012.00141
P577
2012-04-18T00:00:00Z